Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

Active, not recruiting

• Conditions: Sickle Cell Disease
• Interventions: Other: Interviews and Surveys

• Registration Number: NCT02785848
• Lead Sponsor: Vanderbilt University

Brief Summary

The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-05
• Study First Submitted: 2016-05-25
• Study First Submitted QC: 2016-05-27
• Study First Posted: 2016-05-30
• Primary Completion: 2022-05
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-01
• Last Update Posted: 2023-09-05
• Study Completion: 2024-07

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1. Receiving care at the VUMC/Matthew Walker clinic
2. Diagnosed with SCD, asthma, or both
3. Currently taking daily medications for SCD, such as hydroxyurea, asthma, or both
4. Having access to a mobile telephone and/or computer
5. Age 12-70 years

Exclusion Criteria

1. Unable to perform interviews or surveys

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Asthma and/or Sickle Cell Anemia	Interviews and Surveys	The investigators will examine patients with sickle cell disease, asthma, or both who are aged 12-70 years who take daily medications.

Primary Outcome Measures

Name	Time	Method
Number of patients with barriers to medication adherence	1 year	High cost, forgetting, side effects, access to medications

Secondary Outcome Measures

Name	Time	Method
Number of patients that prefer a tailored text messaging technological solution	1 year

Trial Locations

Locations (1)

Vanderbilt University; 🇺🇸 Nashville, Tennessee, United States